Status:
UNKNOWN
Effects of Electrical Nervous Stimulation Transcutaneous in Hypertensive Patients
Lead Sponsor:
Federal University of Health Science of Porto Alegre
Collaborating Sponsors:
Irmandade Santa Casa de Misericórdia de Porto Alegre
Leonhardt Ventures LLC
Conditions:
Hypertension
Hypertension,Essential
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
Systemic arterial hypertension is a disease characterized by high blood pressure levels. It has a high prevalence, is a precursor of cardiovascular diseases, resulting in high costs to the health syst...
Detailed Description
Systemic arterial hypertension is a disease characterized by high blood pressure levels. It has a high prevalence, is a precursor of cardiovascular diseases, resulting in high costs to the health syst...
Eligibility Criteria
Inclusion
- \- Diagnosis of systemic arterial hypertension: systolic blood pressure (SBP) ≥ 130 mmHg and diastolic blood pressure (DBP) ≥ 80 mmHg diagnosed by ambulatory blood pressure monitoring (ABPM).
Exclusion
- Congestive heart failure
- Patients with a cardiac pacemaker
- Previous heart surgery
- Patients with serum creatinine \>2.5 mg/dL
- Change in drug therapy in the two months prior to starting the study
- Active smoking
Key Trial Info
Start Date :
December 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 10 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06025643
Start Date
December 10 2023
End Date
April 10 2024
Last Update
November 30 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.